About
Ltr Pharma Limited — investor relations, events, news, and company updates on 6ix.
Latest News
Today
SPONTAN® Phase II interim data demonstrates rapid onset and pharmacokinetic profile addressing FDA Pre-IND requirements across adult and ≥65 populations
May 1 2026
SPONTAN Phase II data show rapid onset, support FDA pathway
Mar 5 2026
SPONTAN Phase II Clinical Study Completes Recruitment
Feb 26 2026
Appendix 4D and Half Yearly Report
Feb 2 2026
SPONTAN Shows Positive Outcomes in Younger Men with ED
Recent Videos

LTR Pharma starts recruitment for phase II trial of ED nasal spray
Jan 13, 2026

LTR Pharma (ASX:LTP) - Year in Review
Dec 21, 2025

LTR Pharma’s ED nasal spray passes 1000 prescriptions
Dec 17, 2025

LTR Pharma (LTP) REALITY SHOCK: This Isn’t a Biotech Game — It’s a Revolution
Nov 14, 2025
Translate